Clinical Trials in Massachusetts

Showing 7501-7520 of 17,868 trials

Assessment of Updated Educational Materials for Instanyl®

NCT04938440

The purpose of the Instanyl study is to learn how much doctors know and understand about Instanyl® before and after they receive updated educational information, including the risks of its unapproved use. In this study, the doctors will complete two surveys: one three months before they receive the updated educational information, and one about six months after they receive this information. They will answer questions about their prescribing behavior plus their knowledge of Instanyl® including any risks.

PainCancer Pain

Takeda536 participantsStarted Feb 2022

Cambridge, Massachusetts, United States

COMPLETED25 miles

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

NCT00688246

RATIONALE: Learning about the effect of exemestane on bone mineral density in postmenopausal women at increased risk of breast cancer may help plan treatment, decrease the risk of broken bones, and help patients live more comfortably. PURPOSE: This research study is measuring bone mineral density in postmenopausal women at increased risk of developing breast cancer who are receiving exemestane on clinical trial CAN-NCIC-MAP3.

Breast CancerOsteoporosis

NCIC Clinical Trials Group238 participantsStarted Jul 2008

Torrance, California, United States • Washington D.C., District of Columbia, United States • Scarborough, Maine, United States +15 more locations

Assessment of Updated Educational Materials for Instanyl®

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Find Trials by Condition in Massachusetts

Home-based Neuromodulation to Target Depression And Memory Symptoms in Older Adults

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

Look AHEAD: Action for Health in Diabetes

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Postpartum Visit Timing and the Effect on Visit Attendance

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Adapting the Tumor Board Model for Mental Illness and Cancer

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

A Study of PRN1008 in Patients With Pemphigus

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Zalutumumab in Non-curable Patients With SCCHN

Optimising the Duration of Cooling in Mild Encephalopathy